De novo DDX3X missense variants in males appear viable and contribute to syndromic intellectual disability.
DDX3X
developmental delay
intellectual disability
syndromic intellectual disability
Journal
American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
12
09
2018
revised:
12
12
2018
accepted:
04
01
2019
pubmed:
9
2
2019
medline:
23
4
2020
entrez:
9
2
2019
Statut:
ppublish
Résumé
DDX3X (Xp11.4) encodes a DEAD-box RNA helicase that escapes X chromosome inactivation. Pathogenic variants in DDX3X have been shown to cause X-linked intellectual disability (ID) (MRX102, MIM: 300958). The phenotypes associated with DDX3X variants are heterogeneous and include brain and behavioral abnormalities, microcephaly, hypotonia, and movement disorders and/or spasticity. The majority of DDX3X variants described are de novo mutations in females with ID. In contrast, most male DDX3X variants are inherited from an unaffected mother, with one documented exception being a recently identified de novo splice site variant. It has been suggested, therefore, that DDX3X exerts its effects through haploinsufficiency in females, and that affected males carry hypomorphic alleles that retain partial function. Given the lack of male de novo DDX3X variants, loss-of-function variants in this gene are suspected to be male lethal. Through whole-exome sequencing, we identified three unrelated males with hemizygous missense DDX3X variants and ID. All three variants were confirmed by Sanger sequencing, with two established as de novo. In silico analyses were supportive of pathogenicity. We report the male phenotypes and compare them to phenotypes observed in previously reported male and female patients. In conclusion, we propose that de novo DDX3X variants are not necessarily male lethal and should be considered as a cause of syndromic ID in both males and females.
Identifiants
pubmed: 30734472
doi: 10.1002/ajmg.a.61061
doi:
Substances chimiques
DDX3X protein, human
EC 3.6.1.-
DEAD-box RNA Helicases
EC 3.6.4.13
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
570-578Subventions
Organisme : Health Innovation Challenge Fund
ID : HICF-1009-003
Pays : International
Organisme : Wellcome Sanger Institute
ID : WT098051
Pays : International
Organisme : Mayo Clinic
Pays : International
Organisme : National Institute for Health Research
Pays : International
Organisme : Department of Health [UK]
ID : WT098051
Pays : International
Informations de copyright
© 2019 Wiley Periodicals, Inc.